Lidocaine metabolism in isolated perfused liver from streptozotocin-induced diabetic rats

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 8, 2006, Pages 1073-1077

  Gawronska Szklarz, Barbara ^a   Musial, Heros David ^a   Loniewski, Igor ^a   Paprota, Bartosz ^a   Drozdzik, Marek ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DEETHYLLIDOCAINE; DRUG METABOLITE; LIDOCAINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG METABOLISM; ENZYME ACTIVITY; ISOLATED LIVER; LIVER CLEARANCE; LIVER PERFUSION; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ANESTHETICS, LOCAL; ANIMALS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; LIDOCAINE; LIVER; RATS; RATS, WISTAR;

EID: 33747062750     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.8.0008     Document Type: Article

References (34)

1. Ackerman, M. D., Liebman, K. C. (1977) Effect of experimental diabetes on drug metabolism in the rat. Drug Metab. Dispos. 5: 405-410
2. Bargetzi, M. J., Aoyama, T., Gonzales, F. J., Meyer, U. A. (1989) Lidocaine metabolism in human liver microsomes by cytochrome P450 IIIA4. Clin. Pharmacol. Ther. 46: 521-527
3. Chen, Y., Potter, J. M., Ravenscroft, P. J. (1992a) A quick, sensitive high-performance liquid chromatography assay for monoethylglycinxylidide and lignocaine in serum/plasma using solid-phase extraction. Ther. Drug Monit. 14: 315-321
4. Chen, Y., Potter, J. M., Ravenscroft, P. J. (1992b) High-performance liquid chromatographic method for the simultaneous determination of monoethylglycinxylidide and lignocaine. J. Chromatogr. 574: 361-364
5. Cheng, P. Y., Morgan, T. P. (2001) Hepatic cytochrome P450 regulation in disease states. Curr. Drug Metab. 2: 165-183
6. Dajani, R. M., Saheb, S. E. (1974) The metabolic transformation of phenylbutazone in the alloxan diabetic rat. Comp. Gen. Pharmacol. 5: 11-21
7. Dixon, R. L., Hart, L. G., Fouts, J. R. (1961) The metabolism of drugs by liver microsomes from alloxan-diabetic rats. J. Pharmacol. Exp. Ther. 133: 7-11
8. Emudianughe, P., Kalderon, B., Gopher, A., Lapidot, A. (1988) Effects of streptozotocin-induced diabetes on drug metabolism in rats. Arch. Int. Pharmacodyn. Ther. 293: 14-19
9. Fein, F. S., Kornstein, L. B., Strobeck, J. E., Capasso, J. M., Sonnenblick, E. H. (1980) Altered myocardial mechanics in diabetic rats. Circ. Res. 47: 922-933
10. Gawronska-Szklarz, B., Musial, D., Drozdzik, M., Paprota, B. (2003a) Metabolism of lidocaine by liver microsomes from streptozotocin-diabetic rats. Pol. J. Pharmacol. 55: 251-254
11. Gawronska-Szklarz, B., Musial, H. D., Pawlik, A., Paprota, B. (2003b) Effect of experimental diabetes on pharmacokinetic parameters of lidocaine and MEGX in rats. Pol. J. Pharmacol. 55: 619-624
12. Kim, Y. C., Lee, A. K., Lee, J. K., Lee, I., Lee, D. C., Kim, S. H., Kim, S. G., Lee, M. G. (2005) Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formulation. Eur. J. Pharm. Sci. 26: 114-123
13. Klaassen, C. D., Watkins, J. B. (1984) Mechanisms of bile formation, hepatic uptake and biliary excretion. Pharmacol. Rev. 36: 1-67
14. Knodell, R. G., Handwerger, B. S., Morley, J. E., Levine, A. S., Brown, D. M. (1984) Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus. J. Pharmacol. Exp. Ther. 230: 256-262
15. Lin, J. H., De Luna, F. A., Tocco, D. J., Ulm, E. H. (1989) Effect of experimental diabetes on elimination kinetics of diflunisal in rats. Drug Metab. Dispos. 17: 147-152
16. Loch, J. M., Potter, J., Bachmann, K. A. (1995) The influence of anesthetic agents on rat hepatic cytochromes P450 in vivo. Pharmacology 50: 146-153
17. Lucas, P. D., Foy, J. M. (1977) Effects of experimental diabetes and genetic obesity on regional blood flow in the rat. Diabetes 26: 786-792
18. Meftah, N. M., Skett, P. (1989) The role of microsomal phospholipids and their fatty acid composition in the control of hepatic metabolism of lignocaine. Br. J. Pharmacol. 98: 1399-1405
19. Meneguz, A., Fortuna, S., Lorenzini, P., Volpe, M. T. (1999) Influence of urethane and ketamine on rat hepatic cytochrome P450 in vivo. Exp. Toxicol. Pathol. 51: 392-396
20. 14. J. Exp. Med. 94: 31-39
21. Nakamoto, T., Oda, Y., Imaoka, S., Funae, Y., Fujimori, M. (1997) Effect of phenobarbital on the pharmacokinetics of lidocaine, monoethylglycinexylidide and 3-hydroxylidocaine in the rat liver: correlation with P450 isoform levels. Drug. Metab. Dispos. 25: 296-300
22. Orlando, R., Piccoli, P., De Martin, S., Padrini, R., Floreani, M., Palatini, P. (2004) Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function. Clin. Pharmacol. Ther. 75: 80-88
23. Pang, K. S., Terell, J. A., Nelson, S. D. (1986) An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation. J. Pharmacokinet. Biopharm. 14: 107-130
24. Reinke, L. A., Stohs, S. J., Rosenberg, H. (1978) Altered activity of hepatic mixed-function mono-oxygenase enzymes in streptozotocin-induced diabetic rats. Xenobiotica 8: 611-619
25. Renard, C., Van Obberghen E. (2006) Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? Diabetes Metab. 32: 15-29
26. Shimojo, N., Ishizaki, T., Imaoka, S. (1993) Changes in amounts of cytochrome P450 isoenzymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozotocin-induced diabetes. Biochem. Pharmacol. 46: 621-627
27. Skett, P., Joels, L. A. (1985) Different effects of acute and chronic diabetes mellitus on hepatic drug metabolism in the rats. Biochem. Pharmacol. 34: 287-289
28. Sullivan, K. A., Feldman, E. L. (2005) New developments in diabetic neuropathy. Curr. Opin. Neurol. 18: 586-590
29. Thummel, K. E., Schenkman, J. B. (1990) Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat. Mol. Pharmacol. 37: 119-120
30. Tucker, G. T., Mather, L. E. (1979) Clinical pharmacokinetics of local anaesthetics. Clin. Pharmacokinet. 4: 241-278
31. Vega, P., Gaule, C., Mancilla, J., Del Villar, E. (1993) Comparison of alloxan and streptozotocin induced diabetes in rats: differential effects on microsomal drug metabolism. Gen. Pharmacol. 24: 489-495
32. Wang, J. S., Backmann, J. T., Wen, X., Taavitsainen, P., Neuvonen, P. J., Kivisto, K. T. (1999) Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro. Pharmacol. Toxicol. 85: 201-205
33. Warren, B. L., Pak, R., Finlayson, M., Gontownick, L., Sunahara, G., Bessward, G. (1983) Differential effects of diabetes on microsomal metabolism of various substrates. Biochem. Pharmacol. 32: 327-335
34. Watkins, J. B., Dykstra, T. P. (1987) Alterations in biliary excretory function by streptozotocin-induced diabetes. Drug Metab. Dispos. 15: 177-183